Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Neoplasms 2Uterine Cervical Neoplasms 1Respiratory Aspiration 1Pain 1Ovarian Neoplasms 1Meningioma 1Hemorrhage 1Esophageal Neoplasms 1Endometrial Neoplasms 1Disease 1Breast Self-Examination 1Breast Neoplasms 1

Interventions

Cisplatin 161Fluorouracil 135Paclitaxel 127Radiotherapy 125Oxaliplatin 88Docetaxel 71Carboplatin 71Irinotecan 60pembrolizumab 57Leucovorin 57Capecitabine 57Radiation 48Esophagectomy 44Surgical Procedures, Operative 41Drug Therapy 38Neoadjuvant Therapy 28Cetuximab 25Nivolumab 24Bevacizumab 21camrelizumab 20Trastuzumab 20S 1 (combination) 19Chemoradiotherapy 19Magnetic Resonance Spectroscopy 18Epirubicin 16Albumin-Bound Paclitaxel 16Blood Specimen Collection 15tislelizumab 14Taxes 14Radiotherapy, Intensity-Modulated 13

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Esophageal Neoplasms × Sensitivity Training Groups × Clear all
NCT02335970 2020-01-06

Effects of a Training Intervention After Thoracoabdominal Oesophagus Surgery

Göteborg University

Phase NA Completed
64 enrolled
Gastrointestinal

Esophageal Neoplasms, Pain

Data powered by HemOnc (CC BY 4.0) Colophon âš¡